Bilcare Limited (BOM:526853)
71.87
-2.13 (-2.88%)
At close: Nov 6, 2026
Bilcare Revenue
Bilcare had revenue of 2.52B INR in the quarter ending September 30, 2026, with 41.39% growth. This brings the company's total for the last twelve months to 8.38B, up 10.76% year-over-year. In the fiscal year ending March 31, 2026, Bilcare had annual revenue of 7.34B, down -6.92%. That makes Bilcare the 23,551st largest company in the world by revenue and 1,446th in India.
Revenue (ttm)
8.38B
Revenue Growth
+10.76%
P/S Ratio
0.21
Revenue / Employee
155.21M
Employees
54
Market Cap
1.77B
Revenue by Geography
- India 4.74B 64.7%
- outside India 2.59B 35.3%
Fiscal year ended Mar 31, 2026 See the full Bilcare breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 7.34B | -544.99M | -6.92% |
| Mar 31, 2025 | 7.88B | 408.57M | 5.47% |
| Mar 31, 2024 | 7.47B | -2.34B | -23.88% |
| Mar 31, 2023 | 9.82B | 1.37B | 16.21% |
| Mar 31, 2022 | 8.45B | 2.22B | 35.65% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Medico Remedies | 2.38B |
| Sat Kartar Life | 2.24B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Kerala Ayurveda | 1.36B |
| Oxygenta Pharmaceutical | 1.35B |
| Accretion Pharmaceuticals | 1.01B |
| Coral Laboratories | 967.01M |